Zheng Yu Yuan
Founder at MicuRx Pharmaceuticals, Inc.
Profile
Zheng Yu Yuan is the founder of MicuRx Pharmaceuticals, Inc. where he currently holds the title of President, Chief Executive Officer & Director since 2008.
He is also the founder of Shanghai MicuRx Pharmaceutical Co., Ltd.
where he currently holds the title of Chairman & General Manager since 2012.
Dr. Yuan is also the founder of Vicuron Pharmaceuticals LLC.
Dr. Yuan's former job positions include being a Principal at Affymax, Inc., GlaxoWellcome, and Syntex Chemicals, Inc. In terms of education, Dr. Yuan received a doctorate degree from Cornell University in 1988 and an undergraduate degree from Fudan University in 1982.
Zheng Yu Yuan active positions
Companies | Position | Start |
---|---|---|
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Founder | 2007-02-28 |
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | Chief Executive Officer | 2012-08-06 |
Former positions of Zheng Yu Yuan
Companies | Position | End |
---|---|---|
GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - |
Syntex Chemicals, Inc. | Corporate Officer/Principal | - |
AFFYMAX, INC. | Corporate Officer/Principal | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Founder | - |
Training of Zheng Yu Yuan
Cornell University | Doctorate Degree |
Fudan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AFFYMAX, INC. | Health Technology |
Health Technology |
Private companies | 4 |
---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
Syntex Chemicals, Inc. |
- Stock Market
- Insiders
- Zheng Yu Yuan